The 18 kDa translocator protein (TSPO), previously known as the peripheral
benzodiazepine receptor, is expressed in the injured brain. It has become known as an …

For over 15 years, the peripheral benzodiazepine receptor (PBR), recently named
translocator protein 18 kDa (TSPO) has been studied as a biomarker of reactive gliosis and …

The inducible expression of the mitochondrial translocator protein 18 kDa (TSPO) by
activated microglia is a prominent, regular feature of acute and chronic-progressive brain …

Abstract Translocator Protein 18 kDa (TSPO), previously named Peripheral Benzodiazepine
Receptor, is a well-validated and widely used biomarker of neuroinflammation to assess …

The evolutionarily conserved peripheral benzodiazepine receptor (PBR), or 18-kDa
translocator protein (TSPO), is thought to be essential for cholesterol transport and …

The 18 kDa translocator protein (TSPO) is increasingly used to study brain and spinal cord
inflammation in degenerative diseases of the CNS such as multiple sclerosis. The enhanced …

Microglial activation plays central roles in neuroinflammatory and neurodegenerative
diseases. Positron emission tomography (PET) targeting 18 kDa Translocator Protein …

Many studies have explored the role of TSPO (18 kDa translocator protein) as a marker of
neuroinflammation using single-photon emission computed tomography (SPECT) or …

Translocator protein 18 kDa (TSPO) is a mitochondrial outer membrane protein. Although
TSPO expression is up-regulated during neuroinflammation, the role of TSPO and its …

The 18kDa Translocator Protein (TSPO) is the most commonly used tissue-specific marker of
inflammation in positron emission tomography (PET) studies. It is expressed in myeloid cells …